Neutrophil-eosinophil ratio predicts response of kidney cancer to ipilimumab plus nivolumab
Neutrophils and eosinophils are white blood cells. In this study, [...]
Consent forms for clinical trials are too long and complex for patients
A recent survey has shown that informed consent forms used [...]
Neoadjuvant axitinib may reduce venous tumour thrombus in kidney cancer
Neoadjuvant treatment is medication that is given before surgery to [...]
First bivalent COVID-19 booster vaccine approved by UK medicines regulator
An updated version of the COVID-19 vaccine that targets two [...]
COVID-19 and cancer: Immunotherapy and immunosuppressive cancer therapies
This review summarises the outcomes of people with COVID-19 taking [...]
Efficacy of cabozantinib in metastatic MiT family translocation renal cell carcinoma
MiT family translocation renal cell carcinoma is a rare and [...]
Weight loss with cabozantinib use in patients with metastatic kidney cancer
This recent study looked at the effects of cabozantinib on [...]
Role of stereotactic ablative body radiotherapy in kidney cancer
Stereotactic ablative body radiotherapy (SABR) is a procedure that uses [...]
Delayed nephrectomy after immunotherapy for metastatic kidney cancer
Neoadjuvant therapy is the treatment given as a first step [...]
Does the time to start first-line treatment influence survival of patients with low risk kidney cancer?
Many patients with low-risk or favourable-risk kidney cancer may have [...]
